Previous Close | 1.5000 |
Open | 1.5000 |
Bid | 1.4500 x 1000 |
Ask | 1.5400 x 800 |
Day's Range | 1.4200 - 1.5300 |
52 Week Range | 1.1050 - 3.6400 |
Volume | |
Avg. Volume | 79,459 |
Market Cap | 63.199M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Lucid Diagnostics ( NASDAQ:LUCD ) First Quarter 2023 Results Key Financial Results Net loss: US$16.2m (loss widened by...
Key Insights Using the 2 Stage Free Cash Flow to Equity, Lucid Diagnostics fair value estimate is US$2.58 Lucid...
Q4 2022 Lucid Diagnostics Inc Earnings Call
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
A look at the shareholders of Lucid Diagnostics Inc. ( NASDAQ:LUCD ) can tell us which group is most powerful...
Just because a business does not make any money, does not mean that the stock will go down. For example, although...